Transpact IPO description – Transpact Enterprises is a MedTech startup with a focus to provide innovative, cost-effective and comprehensive solutions, products with strategic partnerships and collaborative relationships to help especially abled people to transcend their barriers.
It is a design, development and distribution company for therapeutic device – ‘Vestibulator’ which is a unique and innovative therapeutic design in medical device segment. Vestibulator is ergonomically designed to provide stimulations for vestibular, neuro-developmental and sensory integration therapy. Vestibulator has been incubated at SINE (Society for Innovation and Entrepreneurship), IIT Bombay. Further, a licence agreement had been executed between IIT Bombay and our company to carry out all commercialization activities.
The company has outsourced the manufacturing of its device to third party manufacturer and has entered into a MoU with them for the same. It provides design details required for the manufacturing of the device. Its software solution Rehab-Soft helps Electronic Medical Records (EMR) processing, device administration, communications and streamlines patient billing. The solution is based on Internet of Things (lOT) technologies that turns Vestibulator therapy data into electronic medical record and sends them to the private cloud, where data analytics can be performed to better evaluate patient’s condition.
Transpact promoters – Mr Aslam Khan and Mr Anis Choudhery
Transpact Enterprises – Upcoming IPO details | |
Subscription Dates | 26 – 28 August 2019 |
IPO Price band | INR130 per share |
Fresh issue | 104,000 shares (INR1.35 crore) |
Offer for sale | Nil |
Total IPO size | 104,000 shares (INR1.35 crore) |
Minimum bid (lot size) | 1,000 shares |
Face Value | INR10 per share |
Retail Allocation | 50% |
Listing On | BSE Startup platform |
Transpact Enterprises IPO: Use of funds
- Redemption of preference shares – INR0.29 crore
- Acquisition of R&D facility and registered office on a long term basis – INR0.75 crore
- General corporate purposes – INR0.02 crore
- Issue Expenses – INR0.30 crore
Transpact Enterprises’ financial performance (in INR lakh) | ||||||
FY2017 | FY2018 | FY2019 | ||||
Total revenue | 0.0 | 0.0 | 13.0 | |||
Total expenses | 4.5 | 9.2 | 18.9 | |||
Profit after tax | -4.5 | -9.2 | -7.1 |
Transpact Enterprises Contact Details
Transpact Enterprises LimitedÂ204 2nd Floor, Timmy Arcade
Makwana Road Marol
Andheri East, Mumbai – 400 059 Phone: +91 9224763158
Email: [email protected]
Website:Â www.transpact.in
Transpact IPO Subscription Details
Day | Subscription (no. of times) |
Day 1 | 0.78 |
Day 2 | 0.92 |
Day 3 | 1.06 |
Transpact Enterprises Valuation (For FY2019)
Earnings Per Share (EPS): -INR2.51
Price/Earnings (P/E) ratio: NA
Return on Net Worth (RONW): -28.22%
Net Asset Value (NAV): INR0.40 per share
Registrar of Transpact IPO
Bigshare Services Private LimitedÂE2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E)
Mumbai – 400 072 Phone: +91 22 4043 0200Â
Fax:Â +91 22Â 2847Â 5201
Email:Â [email protected]
Website:Â www.bigshareonline.com
Transpact IPO Allotment Status
Transpact Enterprises IPO allotment status is now available on Bigshare Services’ website. Click on this link to get allotment status.
Listing performance of Transpact Enterprises
IPO Opening Date: 26 August 2019
IPO Closing Date: 28 August 2019
Listing Date: 5 September 2019
Listing Price on BSE Startup Exchange: INR132.5 per share (up 1.92% from IPO price)
Closing Price on BSE Startup Exchange: INR131 per share (up 0.77% from IPO price)